PODCAST: Dr. Goldfischer on OAB

August 28, 2012

PODCAST Efficacy and safety study comparing Oxybutynin 3% topical gel vs. placebo in adults with Overactive Bladder Syndrome.



PODCAST: Dr. Goldfischer on OAB

Efficacy and safety study comparing Oxybutynin 3% topical gel vs. placebo in adults with Overactive Bladder Syndrome.